Tamara A Favorito
CIK 1288232 · CFO, Secretary, Treasurer · last filed 2026-07-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ZVRA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
5740 FLEET STREET
CARLSBAD, CA 92008
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARTL | Director | — | $3.26 | — | $0 | 5 | 2026-07-21 |
| ZVRA | Director | 3,894 | $11.39 | $44.4K | $27.2K | 7 | 2026-06-18 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | — | $0.01 | — | $0 | 6 | 2024-03-01 |
| TuHURA Biosciences, Inc./NV (KTRA) Delisted | Director | — | $7.54 | — | $0 | 4 | 2023-09-01 |
| ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Director | 200 | $5.81 | $1.2K | $974 | 2 | 2022-06-30 |
| Viridian Therapeutics, Inc.\DE (SGNL) Delisted | CFO, Secretary, Treasurer | 4,433 | — | — | $0 | 6 | 2016-11-02 |
| MMRGlobal, Inc. (FVRL) Delisted | CFO | 45,640 | — | — | $0 | 3 | 2008-04-28 |
Recent Filings · Page 2 of 4
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-01 | TuHURA Biosciences, Inc./NV (KTRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-08 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2023-05-08 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2023-03-21 | ZVRA | Buy (P) | +519 | $2.5K | EDGAR |
| 2022-07-05 | TuHURA Biosciences, Inc./NV (KTRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-30 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-24 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +200 | $974 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.